USFDA gives tentative nod for Lupin diabetes drug Sitagliptin Ruchika Sharma16 Dec 2023 11:30 AM ISTSitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2...
Lupin Diagnostics unveils Regional Reference Laboratory in Chennai Ruchika Sharma15 Dec 2023 11:30 AM ISTChennai: Global pharma major Lupin Limited has announced the launch of its new state-of-the-art Regional Reference Laboratory in Chennai, Tamil...
Lupin bags USFDA nod for Varenicline Tablets for smoking cessation treatment Ruchika Sharma6 Dec 2023 11:30 AM ISTVarenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
Include Ankle Brachial Index test to exclude peripheral artery disease: CDSCO Panel Tells Lupin on Denosumab PK/PD study Dr. Divya Colin2 Dec 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin unveils generic contraceptive drug in US Ruchika Sharma2 Dec 2023 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg, after...
USFDA approves Lupin Bromfenac Ophthalmic Solution Ruchika Sharma24 Nov 2023 12:30 PM ISTBromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have...
Lupin type 2 diabetes drug Canagliflozin bags USFDA tentative approval Ruchika Sharma24 Nov 2023 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin Dapagliflozin Tablets gets tentative USFDA okay Ruchika Sharma22 Nov 2023 1:30 PM ISTDapagliflozin Tablets are used for the treatment of type 2 diabetes.
Lupin gets USFDA nod for cholesterol lowering drug Pitavastatin Ruchika Sharma22 Nov 2023 11:37 AM ISTThe product will be manufactured at Lupin's Pithampur facility in India.
Lupin gets USFDA approval for Ganirelix Acetate Injection Ruchika Sharma18 Nov 2023 11:36 AM ISTGanirelix Acetate Injection is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian...
Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region Ruchika Sharma11 Nov 2023 10:00 AM ISTMumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across...
Lupin unveils Rocuronium Bromide Injection in US Ruchika Sharma8 Nov 2023 2:30 PM ISTMumbai: Global pharma major Lupin Limited today announced the launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10...
